Medstone STS Lithotripter Approvable For Gallstone Treatment - FDA Panel
This article was originally published in The Gray Sheet
Executive Summary
Medstone International should conduct post-approval studies of its STS lithotripter in combination with Novartis' Actigall (ursodiol) anti-gallstone drug to fragment biliary stones, FDA's Gastroenterology and Urology Devices Panel recommended April 30.